{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:37:56Z","timestamp":1793090276458,"version":"4.5.0"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105563","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:56:13Z","timestamp":1787669773000},"page":"105563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Histone erasers in prostate cancer: Clearing the path for progression &amp; therapy resistance"],"prefix":"10.1016","volume":"227","author":[{"given":"Buse","family":"Cevatemre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Yuksel-Catal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Karyemez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9573-7491","authenticated-orcid":false,"given":"Deniz","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceyda","family":"Acilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105563_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13020296","article-title":"Natural compounds and histone deacetylase inhibitors: a combined approach against mCRPC cells","volume":"13","author":"Alimudin","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2026.105563_bib2","article-title":"Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence","volume":"6","author":"Arce-Gallego","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.critrevonc.2026.105563_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111777","article-title":"The novel selective HDAC1 inhibitor ZJH-1 exhibits potent antitumor activity in castration-resistant prostate cancer, potentially involving HSP90AA1","volume":"421","author":"Bao","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.critrevonc.2026.105563_bib4","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1038\/onc.2011.512","article-title":"Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion","volume":"31","author":"Bjorkman","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105563_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/pros.24706","article-title":"Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis","volume":"84","author":"Brown","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.critrevonc.2026.105563_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.yexmp.2015.03.024","article-title":"HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer","volume":"98","author":"Burdelski","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068003","article-title":"Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells","volume":"8","author":"Burton","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.critrevonc.2026.105563_bib8","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1038\/onc.2011.612","article-title":"SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis","volume":"31","author":"Byles","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105563_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12885-023-10915-1","article-title":"JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance","volume":"23","author":"Cai","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib10","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1038\/s41598-022-16610-8","article-title":"SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism","volume":"12","author":"Cai","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105563_bib11","doi-asserted-by":"crossref","first-page":"59165","DOI":"10.18632\/oncotarget.19467","article-title":"Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells","volume":"8","author":"Canovas","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41419-020-03354-4","article-title":"KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer","volume":"12","author":"Cao","year":"2021","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105563_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115250","article-title":"Discovery of a novel 1H-pyrazole- [3,4-b] pyridine-based lysine demethylase 5B inhibitor with potential anti-prostate cancer activity that perturbs the phosphoinositide 3-kinase\/AKT pathway","volume":"251","author":"Cao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib14","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1210\/en.2006-0502","article-title":"Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak","volume":"147","author":"Castilla","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.critrevonc.2026.105563_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-024-06422-1","article-title":"Exploiting epigenetic targets to overcome taxane resistance in prostate cancer","volume":"15","author":"Cevatemre","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105563_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.55730\/1300-0152.2778","article-title":"Identification of epigenetic monotherapy candidates in taxane-resistant CRPC","volume":"49","author":"Cevatemre","year":"2025","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061769","article-title":"Antiandrogen-equipped histone deacetylase inhibitors selectively inhibit androgen receptor (AR) and AR-splice variant (AR-SV) in castration-resistant prostate cancer (CRPC)","volume":"15","author":"Chandrasekaran","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105563_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12885-020-06776-7","article-title":"Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/pros.23709","article-title":"NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer","volume":"79","author":"Chen","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.critrevonc.2026.105563_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10565-025-10091-x","article-title":"Ginsenoside Rh2 targets SIRT1-mediated deacetylation to modulate ERalpha\/AR balance and overcome endocrine therapy resistance in prostate cancer using 3D organoid models","volume":"41","author":"Chen","year":"2025","journal-title":"Cell. Biol. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12916-023-03094-0","article-title":"A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy","volume":"21","author":"Chen","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.critrevonc.2026.105563_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918783132","article-title":"HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9","volume":"10","author":"Chen","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5114\/aoms.2020.92939","article-title":"CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K\/Akt signaling pathway in prostate cancer","volume":"17","author":"Chen","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105563_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13578-023-01157-6","article-title":"The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment","volume":"13","author":"Cheng","year":"2023","journal-title":"Cell. Biosci."},{"key":"10.1016\/j.critrevonc.2026.105563_bib25","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.cellsig.2011.04.008","article-title":"AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia","volume":"23","author":"Chhipa","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.critrevonc.2026.105563_bib26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.21873\/anticanres.14895","article-title":"Expression patterns of ERalpha, ERbeta, AR, SIRT1, SIRT2, and SIRT3 in prostate cancer tissue and normal prostate tissue","volume":"41","author":"Choi","year":"2021","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.21873\/cgp.20303","article-title":"SIRT5 directly inhibits the PI3K\/AKT pathway in prostate cancer cell lines","volume":"19","author":"Choi","year":"2022","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.critrevonc.2026.105563_bib28","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1038\/s41598-021-01003-0","article-title":"a. ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT)","volume":"11","author":"Choi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105563_bib29","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1021\/jm500249n","article-title":"KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor","volume":"57","author":"Chu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1476-4598-11-52","article-title":"The emerging role of histone lysine demethylases in prostate cancer","volume":"11","author":"Crea","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib31","unstructured":"Cui, A.-N.M.F., Bo, X., Hu, J., Liu, T., Adebis, M.K., Salim, S.A. & Kanton, A.G. 2020. SIRT4 Overexpression Promotes the Inhibition of Cell Proliferation and Invasion in Prostate Cancer."},{"key":"10.1016\/j.critrevonc.2026.105563_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1770249","article-title":"The pterocarpan (+)-PTC modulates cytoskeletal proteins and induces apoptosis in metastatic castration-resistant prostate cancer: a proteomic perspective","volume":"17","author":"De Brito Vieira Neto","year":"2026","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.critrevonc.2026.105563_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031860","article-title":"Combination treatment of a phytochemical and a histone demethylase inhibitor-a novel approach towards targeting TGFbeta-induced EMT, invasion, and migration in prostate cancer","volume":"24","author":"Dalpatraj","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105563_bib34","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1186\/s12885-017-3853-9","article-title":"Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes","volume":"17","author":"Damodaran","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib35","doi-asserted-by":"crossref","first-page":"23413","DOI":"10.18632\/oncotarget.25182","article-title":"A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2","volume":"9","author":"Daures","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12950-015-0057-4","article-title":"Inflammation contributes to NKX3.1 loss and augments DNA damage but does not alter the DNA damage response via increased SIRT1 expression","volume":"12","author":"Debelec-Butuner","year":"2015","journal-title":"J. Inflamm. (Lond. )"},{"key":"10.1016\/j.critrevonc.2026.105563_bib37","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/ijc.27876","article-title":"HDAC11 is a novel drug target in carcinomas","volume":"132","author":"Deubzer","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13046-019-1516-1","article-title":"SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer","volume":"39","author":"Ding","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13046-020-01735-3","article-title":"Activation of the KDM5A\/miRNA-495\/YTHDF2\/m6A-MOB3B axis facilitates prostate cancer progression","volume":"39","author":"Du","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114077","article-title":"Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer","volume":"158","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105563_bib41","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.aad9512","article-title":"Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation","volume":"352","author":"Dutta","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105563_bib42","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1038\/onc.2015.309","article-title":"Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival","volume":"35","author":"Fan","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105563_bib43","doi-asserted-by":"crossref","first-page":"E4584","DOI":"10.1073\/pnas.1802415115","article-title":"Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells","volume":"115","author":"Fan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105563_bib44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(01)00429-4","article-title":"Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT\/N-CoR","volume":"9","author":"Fischle","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1016\/j.critrevonc.2026.105563_bib45","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.4161\/cc.7.22.7062","article-title":"KDM2A represses transcription of centromeric satellite repeats and maintains the heterochromatic state","volume":"7","author":"Frescas","year":"2008","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.critrevonc.2026.105563_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8820355","article-title":"The SIRT3 and SIRT6 promote prostate cancer progression by inhibiting necroptosis-mediated innate immune response","volume":"2020","author":"Fu","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib47","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.18632\/oncotarget.7180","article-title":"Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells","volume":"7","author":"Gameiro","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2021.07.012","article-title":"UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications","volume":"520","author":"Gao","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105563_bib49","doi-asserted-by":"crossref","first-page":"38095","DOI":"10.1074\/jbc.M111.257055","article-title":"HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia","volume":"286","author":"Geng","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1295613","article-title":"Methylation of the epigenetic JMJD2D protein by SET7\/9 promotes prostate tumorigenesis","volume":"13","author":"Gu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib51","doi-asserted-by":"crossref","first-page":"14039","DOI":"10.1111\/jcmm.16016","article-title":"Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl-CoA acetyltransferase 1","volume":"24","author":"Guan","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105563_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116494","article-title":"Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer","volume":"272","author":"Guan","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib53","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1158\/1541-7786.MCR-20-0975","article-title":"Circulating tumor cell genomic evolution and hormone therapy outcomes in men with metastatic castration-resistant prostate cancer","volume":"19","author":"Gupta","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib54","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.18632\/oncotarget.2154","article-title":"Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells","volume":"5","author":"Ha","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.eururo.2003.10.005","article-title":"Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate","volume":"45","author":"halkidou","year":"2004","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pros.20022","article-title":"Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer","volume":"59","author":"Halkidou","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.critrevonc.2026.105563_bib57","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.7150\/thno.53886","article-title":"Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105563_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12032-022-01814-9","article-title":"Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer","volume":"39","author":"Han","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1878-0261.12030","article-title":"The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer","volume":"11","author":"Hanrahan","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/CBI20090030","article-title":"A mutation in beta-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line","volume":"34","author":"Hara","year":"2010","journal-title":"Cell. Biol. Int."},{"key":"10.1016\/j.critrevonc.2026.105563_bib61","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1158\/1541-7786.MCR-19-1037","article-title":"beta2-adrenoreceptor signaling increases therapy resistance in prostate cancer by upregulating MCL1","volume":"18","author":"Hassan","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib62","article-title":"Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers","volume":"13","author":"He","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib63","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1038\/s41388-022-02311-z","article-title":"H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity","volume":"41","author":"He","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105563_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108793","article-title":"KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN","volume":"114","author":"Hong","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105563_bib65","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3389\/fonc.2020.01474","article-title":"Increased ABCC4 expression induced by ERRalpha leads to docetaxel resistance via efflux of docetaxel in prostate cancer","volume":"10","author":"Huang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib66","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mc.23412","article-title":"SIRT1 inhibition-induced senescence as a strategy to prevent prostate cancer progression","volume":"61","author":"Huang","year":"2022","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2026.105563_bib67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2021.02.008","article-title":"Androgen deprivation-induced elevated nuclear SIRT1 promotes prostate tumor cell survival by reactivation of AR signaling","volume":"505","author":"Huang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105563_bib68","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.18632\/oncotarget.3040","article-title":"DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance","volume":"6","author":"Huber","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib69","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1158\/0008-5472.CAN-07-0085","article-title":"SIRT1 is significantly elevated in mouse and human prostate cancer","volume":"67","author":"Huffman","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib70","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3892\/or.2020.7680","article-title":"Long non\u2011coding RNA BCYRN1 promotes prostate cancer progression via elevation of HDAC11","volume":"44","author":"Huo","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105563_bib71","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.juro.2010.07.035","article-title":"Histone deacetylase inhibitor potentiates anticancer effect of docetaxel via modulation of Bcl-2 family proteins and tubulin in hormone refractory prostate cancer cells","volume":"184","author":"Hwang","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib72","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s10637-019-00746-y","article-title":"Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-(XL)","volume":"37","author":"Hwang","year":"2019","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105563_bib73","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/0008-5472.CAN-12-2730","article-title":"Tasquinimod is an allosteric modulator of HDAC4 survival signaling within the compromised cancer microenvironment","volume":"73","author":"Isaacs","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib74","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/pros.24606","article-title":"Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1alpha, and MEF-2 signaling for metastatic castration-resistant prostate cancer","volume":"83","author":"Isaacs","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.critrevonc.2026.105563_bib75","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1248\/bpb.b18-00782","article-title":"Class IIb HDAC inhibition enhances the inhibitory effect of Am80, a synthetic retinoid, in prostate cancer","volume":"42","author":"Ishigami-Yuasa","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.critrevonc.2026.105563_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108444","article-title":"Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression","volume":"84","author":"Jang","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.70238","article-title":"KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer","author":"Jeyapalan","year":"2026","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib78","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1158\/2159-8290.CD-25-0974","article-title":"Serotonin modulates lineage plasticity in neuroendocrine prostate cancer via epigenetic reprogramming","volume":"16","author":"Ji","year":"2026","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105563_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116315","article-title":"Discovery of novel itaconimide-based derivatives as potent HDAC inhibitors for the efficient treatment of prostate cancer","volume":"269","author":"Jiang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib80","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.molcel.2018.06.036","article-title":"DUB3 promotes BET inhibitor resistance and cancer progression by deubiquitinating BRD4","volume":"71","author":"Jin","year":"2018","journal-title":"Mol. Cell."},{"key":"10.1016\/j.critrevonc.2026.105563_bib81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s42003-023-05741-x","article-title":"DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2\/PRC2","volume":"7","author":"Kaarijarvi","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib82","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1158\/0008-5472.CAN-06-1570","article-title":"Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence","volume":"66","author":"Kahl","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2018.05.014","article-title":"Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics","volume":"430","author":"Kanwal","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105563_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143575","article-title":"HDAC inhibitors: dissecting mechanisms of action to counter tumor heterogeneity","volume":"13","author":"Karagiannis","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105563_bib85","first-page":"101","article-title":"Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors","volume":"14","author":"Kim","year":"2023","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib86","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI78132","article-title":"Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1","volume":"126","author":"Kim","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105563_bib87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/1120009X.2021.1963615","article-title":"Effect of HDAC9 inhibition on epithelial-mesenchymal transition in CD133+ prostate cancer cell lines","volume":"34","author":"Kim","year":"2022","journal-title":"J. Chemother."},{"key":"10.1016\/j.critrevonc.2026.105563_bib88","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2008.06.045","article-title":"A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells","volume":"373","author":"Kojima","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105563_bib89","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI96769","article-title":"ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D","volume":"128","author":"Komura","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105563_bib90","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1038\/s41467-023-41067-2","article-title":"The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG","volume":"14","author":"Kugler","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105563_bib91","article-title":"Targeting epigenetic regulators: In-silico discovery of natural inhibitors against histone demethylase KDM4C","volume":"21","author":"Kumar","year":"2026","journal-title":"PLoS. One"},{"key":"10.1016\/j.critrevonc.2026.105563_bib92","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167440","article-title":"LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function","volume":"8","author":"Kumaraswamy","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2026.105563_bib93","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.gpb.2022.02.004","article-title":"LDHA desuccinylase sirtuin 5 as a novel cancer metastatic stimulator in aggressive prostate cancer","volume":"21","author":"Kwon","year":"2023","journal-title":"Genom. Proteom. Bioinforma."},{"key":"10.1016\/j.critrevonc.2026.105563_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040295","article-title":"CD44 promotes migration and invasion of docetaxel-resistant prostate cancer cells likely via induction of hippo-yap signaling","volume":"8","author":"Lai","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105563_bib95","article-title":"Epigenetic activation of CCDC183-AS1 promotes osteoclastogenesis and prostate cancer bone metastasis through the FUBP1\/LIGHT axis","volume":"12","author":"Lang","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.critrevonc.2026.105563_bib96","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R","article-title":"Expression analysis of thirty one Y chromosome genes in human prostate cancer","volume":"27","author":"Lau","year":"2000","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2026.105563_bib97","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/ijc.31843","article-title":"Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer","volume":"143","author":"Lee","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib98","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13046-021-02147-7","article-title":"TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1","volume":"40","author":"Lee","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081894","article-title":"Histone demethylase KDM5C drives prostate cancer progression by promoting EMT","volume":"14","author":"Lemster","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105563_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2023.05.007","article-title":"Elevated PSPC1 and KDM5C expression indicates poor prognosis in prostate cancer","volume":"138","author":"Lemster","year":"2023","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib101","article-title":"Phase separation of NFIB suppresses SLC3A2-mediated ferroptosis in castration-resistant prostate cancer","volume":"13","author":"Li","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105563_bib102","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-15-0906","article-title":"JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib103","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1158\/0008-5472.CAN-20-0505","article-title":"a. KDM5B is essential for the hyperactivation of PI3K\/AKT signaling in prostate tumorigenesis","volume":"80","author":"Li","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib104","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.7150\/thno.42874","article-title":"Mitochondrial PAK6 inhibits prostate cancer cell apoptosis via the PAK6-SIRT4-ANT2 complex","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105563_bib105","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/0008-5472.CAN-22-2433","article-title":"a. LSD1 inhibition disrupts super-enhancer-driven oncogenic transcriptional programs in castration-resistant prostate cancer","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib106","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yexcr.2018.01.036","article-title":"SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt\/beta-catenin pathway","volume":"364","author":"Li","year":"2018","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154938","article-title":"Synergistic effect of docetaxel combined with a novel multi-target inhibitor CUDC-101 on inhibiting human prostate cancer","volume":"252","author":"Li","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.critrevonc.2026.105563_bib108","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ccell.2023.06.010","article-title":"Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105563_bib109","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2241118","article-title":"Discovery and biological evaluation of novel CARM1\/HDAC2 dual-targeting inhibitors with anti-prostate cancer agents","volume":"38","author":"Liang","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib110","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1158\/1078-0432.CCR-20-3260","article-title":"Emergence of enzalutamide resistance in prostate cancer is associated with BCL-2 and IKKB dependencies","volume":"27","author":"Liang","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib111","article-title":"LSD1 promotes prostate cancer cell proliferation by upregulating PRAC1 expression","volume":"16","author":"Liao","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105563_bib112","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/s41388-021-01658-z","article-title":"Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105563_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111785","article-title":"Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc","volume":"11","author":"Lin","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105563_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.764","article-title":"Inhibition of KDM4C\/c-Myc\/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism","volume":"12","author":"Lin","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105563_bib115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.canlet.2019.11.014","article-title":"FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK\/mTOR-mediated autophagy","volume":"469","author":"Lin","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105563_bib116","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pros.24437","article-title":"SIRT2 promotes cell proliferation and migration through mediating ERK1\/2 activation and lactosylceramide accumulation in prostate cancer","volume":"83","author":"Lin","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.critrevonc.2026.105563_bib117","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41568-026-00922-2","article-title":"Advancing AI for multi-omics and clinical data integration in basic and translational cancer research","volume":"26","author":"Liu","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib118","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-022-00812-3","article-title":"Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer","volume":"29","author":"Liu","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.critrevonc.2026.105563_bib119","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.18632\/oncotarget.27818","article-title":"Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer","volume":"11","author":"Liu","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/path.5557","article-title":"Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2","volume":"253","author":"Liu","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib121","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s13238-013-3054-5","article-title":"Inhibition of SIRT6 in prostate cancer reduces cell viability and increases sensitivity to chemotherapeutics","volume":"4","author":"Liu","year":"2013","journal-title":"Protein Cell."},{"key":"10.1016\/j.critrevonc.2026.105563_bib122","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/pros.22592","article-title":"SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells","volume":"73","author":"Lovaas","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.critrevonc.2026.105563_bib123","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41588-022-01045-8","article-title":"HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer","volume":"54","author":"Lu","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2026.105563_bib124","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.195743","article-title":"Targeting p300 and CBP abolishes HOXB13-loss-induced lipogenesis and tumor metastasis","volume":"10","author":"Lu","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2026.105563_bib125","first-page":"1979","article-title":"The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b","volume":"8","author":"Ma","year":"2015","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.critrevonc.2026.105563_bib126","first-page":"157","article-title":"Synergistic antitumor effect of MK-1775 and CUDC-907 against prostate cancer","volume":"43","author":"Ma","year":"2025","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105563_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147841","article-title":"The epigenetic modifiers HDAC2 and HDAC7 inversely associate with cancer stemness and immunity in solid tumors","volume":"25","author":"Maciejewski","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105563_bib128","article-title":"Salvianolic acid activates ATP-driven mitochondrial biogenesis to suppress the epithelial\u2013mesenchymal transition in LNCaP prostate cancer cells","volume":"2026","author":"Mai","year":"2026","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"10.1016\/j.critrevonc.2026.105563_bib129","doi-asserted-by":"crossref","first-page":"75585","DOI":"10.18632\/oncotarget.12310","article-title":"c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer","volume":"7","author":"Maina","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218184","article-title":"KDM4A promotes NEPC progression through regulation of MYC expression","volume":"638","author":"Mak","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105563_bib131","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1038\/srep09841","article-title":"SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors","volume":"5","author":"Malik","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105563_bib132","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/mc.22996","article-title":"Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: relevance of statins in chemosensitization","volume":"58","author":"Mallappa","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2026.105563_bib133","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5498743","article-title":"Sirtuin 4 inhibits prostate cancer progression and metastasis by modulating p21 nuclear translocation and glutamate dehydrogenase 1 ADP-ribosylation","volume":"2022","author":"Mao","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib134","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/pros.23467","article-title":"Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer","volume":"78","author":"Mcleod","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.critrevonc.2026.105563_bib135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature04020","article-title":"LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription","volume":"437","author":"Metzger","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105563_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1116424","article-title":"The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer","volume":"11","author":"Metzler","year":"2023","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib137","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12079-022-00671-5","article-title":"Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2\/PI3K\/AKT axis in an ETS1-dependent manner","volume":"16","author":"Mi","year":"2022","journal-title":"J. Cell. Commun. Signal."},{"key":"10.1016\/j.critrevonc.2026.105563_bib138","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13058-015-0534-y","article-title":"Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells","volume":"17","author":"Min","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115730","article-title":"Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer","volume":"260","author":"Moi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216333","article-title":"A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression","volume":"571","author":"Naderinezhad","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105563_bib141","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41389-024-00533-2","article-title":"Correction: dihydroartemisinin inhibits prostate cancer via JARID2\/miR-7\/miR-34a-dependent downregulation of Axl","volume":"13","author":"Paccez","year":"2024","journal-title":"Oncogenesis"},{"key":"10.1016\/j.critrevonc.2026.105563_bib142","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bcp.2010.11.006","article-title":"Synergistic antimicrotubule therapy for prostate cancer","volume":"81","author":"Pannu","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2024.102109","article-title":"Role of KDM2B epigenetic factor in regulating calcium signaling in prostate cancer cells","volume":"32","author":"Pantazaka","year":"2024","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.critrevonc.2026.105563_bib144","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/ptr.8115","article-title":"Inhibition of glycolysis and SIRT1\/GLUT1 signaling ameliorates the apoptotic effect of Leptosidin in prostate cancer cells","volume":"38","author":"Park","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/ph17081072","article-title":"Searching for novel HDAC6\/Hsp90 dual inhibitors with anti-prostate cancer activity: in silico screening and in vitro evaluation","volume":"17","author":"Pinzi","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.critrevonc.2026.105563_bib146","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1158\/0008-5472.CAN-10-1447","article-title":"Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy","volume":"70","author":"Ploussard","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib147","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/kjm2.12766","article-title":"EGFR-mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells","volume":"40","author":"Pu","year":"2024","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105563_bib148","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccr.2010.05.024","article-title":"Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors","volume":"18","author":"Qi","year":"2010","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105563_bib149","article-title":"LSD1 promotes prostate cancer cell survival by destabilizing FBXW7 at post-translational level","volume":"10","author":"Qin","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib150","doi-asserted-by":"crossref","first-page":"26494","DOI":"10.18632\/oncotarget.4764","article-title":"SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K\/Akt pathway","volume":"6","author":"Quan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8020022","article-title":"Understanding failure and improving treatment using HDAC inhibitors for prostate cancer","volume":"8","author":"Rana","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2026.105563_bib152","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.biocel.2008.10.015","article-title":"Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers","volume":"41","author":"Ren","year":"2009","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib153","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4062\/biomolther.2019.074","article-title":"A new histone deacetylase inhibitor, MHY4381, induces apoptosis via generation of reactive oxygen species in human prostate cancer cells","volume":"28","author":"Richa","year":"2020","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105563_bib154","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrurol.2016.225","article-title":"The role of GATA2 in lethal prostate cancer aggressiveness","volume":"14","author":"Rodriguez-Bravo","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib155","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.18632\/oncotarget.23111","article-title":"SIRT1 contributes to neuroendocrine differentiation of prostate cancer","volume":"9","author":"Ruan","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib156","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1158\/1541-7786.MCR-16-0270-T","article-title":"The efflux transporter ABCG2 maintains prostate stem cells","volume":"15","author":"Sabnis","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib157","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13072-025-00595-5","article-title":"Artificial Intelligence in cancer epigenomics: a review on advances in pan-cancer detection and precision medicine","volume":"18","author":"Sahoo","year":"2025","journal-title":"Epigenet. Chromatin"},{"key":"10.1016\/j.critrevonc.2026.105563_bib158","doi-asserted-by":"crossref","first-page":"339","DOI":"10.21873\/cgp.20324","article-title":"Effects of GSK-J4 on JMJD3 histone demethylase in mouse prostate cancer xenografts","volume":"19","author":"Sanchez","year":"2022","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.critrevonc.2026.105563_bib159","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41388-019-1116-8","article-title":"Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer","volume":"39","author":"Sarac","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105563_bib160","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-25-0070","article-title":"Identification of protein-coding genes associated with metastatic prostate cancer","volume":"32","author":"Sattari","year":"2025","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib161","first-page":"50","article-title":"Transcriptional repression of SIRT3 potentiates mitochondrial aconitase activation to drive aggressive prostate cancer to the bone","volume":"81","author":"Sawant Dessai","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib162","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.21037\/tau-20-1084","article-title":"KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patients","volume":"10","author":"Schafer","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib163","doi-asserted-by":"crossref","first-page":"E4179","DOI":"10.1073\/pnas.1719168115","article-title":"LSD1 activates a lethal prostate cancer gene network independently of its demethylase function","volume":"115","author":"Sehrawat","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105563_bib164","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/mc.23214","article-title":"Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer","volume":"59","author":"Shankar","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2026.105563_bib165","first-page":"73","article-title":"Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer","volume":"6","author":"Shuai","year":"2026","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.critrevonc.2026.105563_bib166","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105563_bib167","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1038\/s41388-019-0774-x","article-title":"Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer","volume":"38","author":"Sinha","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105563_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.113991","article-title":"The KDM5 inhibitor PBIT reduces proliferation of castration-resistant prostate cancer cells via cell cycle arrest and the induction of senescence","volume":"437","author":"Smith","year":"2024","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib169","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s13205-024-04163-8","article-title":"Jumonji and AT-rich interacting domain 2 (JARID2) exhibits a tumor-suppressive role in oral squamous cell carcinoma by modulating tumor progression and metastasis","volume":"14","author":"Sreeshma","year":"2024","journal-title":"3 Biotech"},{"key":"10.1016\/j.critrevonc.2026.105563_bib170","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.ajpath.2014.05.022","article-title":"KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy","volume":"184","author":"Stein","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib171","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2016.66.9697","article-title":"Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer","volume":"34","author":"Sternberg","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib172","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2890","article-title":"Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B","volume":"18","author":"Sun","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105563_bib173","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-026-02602-z","article-title":"KDM5B-driven glucose metabolic reprogramming promotes enzalutamide resistance in prostate cancer via the lactate\/hnRNPA1 lactylation\/AR-V7 axis","volume":"25","author":"Sun","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib174","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12672-016-0257-2","article-title":"CUDC-101, a novel inhibitor of full-length androgen receptor (flAR) and androgen receptor variant 7 (AR-V7) activity: mechanism of action and in vivo efficacy","volume":"7","author":"Sun","year":"2016","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib175","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105563_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010053","article-title":"MDA-9\/syntenin (SDCBP) is a critical regulator of chemoresistance, survival and stemness in prostate cancer stem cells","volume":"12","author":"Talukdar","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105563_bib177","first-page":"OF1","article-title":"Correction: targeting KDM6A suppresses SREBP1c-dependent lipid metabolism and prostate tumorigenesis","author":"Tang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib178","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/path.5495","article-title":"Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer","volume":"252","author":"Tang","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib179","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.62347\/QWZY6886","article-title":"PGC1alpha as a downstream effector of KDM5B promotes the progression of androgen receptor-positive and androgen receptor-negative prostate cancers","volume":"14","author":"Teramoto","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib180","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.74","article-title":"The HIF\/PHF8\/AR axis promotes prostate cancer progression","volume":"5","author":"Tong","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.critrevonc.2026.105563_bib181","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf169","article-title":"Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors","volume":"30","author":"Tsimberidou","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2026.105563_bib182","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0168-9525(03)00073-8","article-title":"Class II histone deacetylases: versatile regulators","volume":"19","author":"Verdin","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.critrevonc.2026.105563_bib183","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-026-04448-8","article-title":"Prevalence of KDM6A deficiency in human cancer: a tissue microarray study on 18,570 cancers from 153 different tumor types","author":"Viehweger","year":"2026","journal-title":"Virchows Arch."},{"key":"10.1016\/j.critrevonc.2026.105563_bib184","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/ERC-13-0375","article-title":"Deregulated expression of selected histone methylases and demethylases in prostate carcinoma","volume":"21","author":"Vieira","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib185","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1039\/D1CB00244A","article-title":"Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration","volume":"3","author":"Vogelmann","year":"2022","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib186","doi-asserted-by":"crossref","first-page":"18302","DOI":"10.1074\/jbc.M114.555052","article-title":"Human UTY(KDM6C) is a male-specific N\u03f5-methyl lysyl demethylase","volume":"289","author":"Walport","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib187","doi-asserted-by":"crossref","unstructured":"Wang, T., Chen, X., Jiang, T., Liu, F., Li, X., Shao, X. & Wu, D. 2022. Bioinformatic determination of the expression and clinical value of the histone lysine demethylase family in prostate cancer.","DOI":"10.21203\/rs.3.rs-1486046\/v1"},{"key":"10.1016\/j.critrevonc.2026.105563_bib188","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ccell.2023.05.016","article-title":"Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105563_bib189","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11255-015-0915-2","article-title":"Relationship between LSD1 expression and E-cadherin expression in prostate cancer","volume":"47","author":"Wang","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41388-018-0414-x","article-title":"KDM8\/JMJD5 as a dual coactivator of AR and PKM2 integrates AR\/EZH2 network and tumor metabolism in CRPC","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105563_bib191","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/path.6325","article-title":"Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1-SNAI1 axis","volume":"264","author":"Wang","year":"2024","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib192","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00280-016-3158-8","article-title":"The UCA1\/miR-204\/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells","volume":"78","author":"Wang","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib193","doi-asserted-by":"crossref","first-page":"397","DOI":"10.18632\/aging.102630","article-title":"The combined effect of epigenetic inhibitors for LSD1 and BRD4 alters prostate cancer growth and invasion","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2026.105563_bib194","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001758","article-title":"ATM\/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer","volume":"9","author":"Wang","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib195","first-page":"62","article-title":"Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA","volume":"1","author":"Wang","year":"2009","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib196","doi-asserted-by":"crossref","first-page":"50507","DOI":"10.18632\/oncotarget.10476","article-title":"Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer","volume":"7","author":"Ware","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib197","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.bjc.6604199","article-title":"Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy","volume":"98","author":"Weichert","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib198","doi-asserted-by":"crossref","first-page":"30328","DOI":"10.18632\/oncotarget.15681","article-title":"The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells","volume":"8","author":"Wilson","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib199","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ncb1546","article-title":"Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression","volume":"9","author":"Wissmann","year":"2007","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib200","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.7150\/thno.58729","article-title":"Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105563_bib201","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/tox.23334","article-title":"Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting SIRT7 expression","volume":"36","author":"Wu","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib202","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.18632\/oncotarget.3594","article-title":"E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105563_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116301","article-title":"Design and biological evaluation of dual tubulin\/HDAC inhibitors based on millepachine for treatment of prostate cancer","volume":"268","author":"Xie","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib204","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/jcmm.13475","article-title":"Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A","volume":"22","author":"Xu","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105563_bib205","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10637-023-01330-1","article-title":"Viscosalactone B, a natural LSD1 inhibitor, inhibits proliferation in vitro and in vivo against prostate cancer cells","volume":"41","author":"Yan","year":"2023","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105563_bib206","first-page":"62","article-title":"Analysis of key genes reveal lysine demethylase 5B promotes prostate cancer progression","volume":"20","author":"Yang","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105563_bib207","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/pros.24678","article-title":"A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancer","volume":"84","author":"Ye","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.critrevonc.2026.105563_bib208","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/molpharm.121.000372","article-title":"Lysine demethylase 6B regulates prostate cancer cell proliferation by controlling c-MYC expression","volume":"101","author":"Yildirim-Buharalioglu","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib209","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1080\/17501911.2025.2586858","article-title":"Epigenetic regulation of MMP-11 and -16 expression in human prostate cancer: the role of KDM6A","volume":"17","author":"Yildirim-Buharalioglu","year":"2025","journal-title":"Epigenomics"},{"key":"10.1016\/j.critrevonc.2026.105563_bib210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-019-0941-2","article-title":"N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421\/ATM pathway","volume":"18","author":"Yin","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib211","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026324118","article-title":"AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase","volume":"118","author":"Yoshihama","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105563_bib212","first-page":"9195","article-title":"Nicotinamide N-methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1","volume":"15","author":"You","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105563_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107784","article-title":"Design, synthesis and biological evaluation of prostate-specific membrane antigen (PSMA)-targeted SIRT2 inhibitors","volume":"153","author":"Yu","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib214","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2510386122","article-title":"A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression","volume":"122","author":"Yuan","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105563_bib215","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/15384047.2020.1736481","article-title":"The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility","volume":"21","author":"Zacharopoulou","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105563_bib216","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbamcr.2018.01.009","article-title":"The epigenetic factor KDM2B regulates cell adhesion, small rho GTPases, actin cytoskeleton and migration in prostate cancer cells","volume":"1865","author":"Zacharopoulou","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib217","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.chembiol.2022.05.008","article-title":"Evidence that HDAC7 acts as an epigenetic \"reader\" of AR acetylation through NCoR-HDAC3 dissociation","volume":"29","author":"Zhang","year":"2022","journal-title":"Cell. Chem. Biol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib218","article-title":"SIRT6 promotes the progression of prostate cancer via regulating the Wnt\/beta-catenin signaling pathway","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib219","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1186\/s12885-022-10263-6","article-title":"The LINC00852\/miR-29a-3p\/JARID2 axis regulates the proliferation and invasion of prostate cancer cell","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105563_bib220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ccell.2020.06.005","article-title":"Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer","volume":"38","author":"Zhang","year":"2020","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105563_bib221","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1186\/s40001-025-03371-z","article-title":"KDM3B suppresses castration-resistance prostate cancer cell proliferation by promoting PTEN expression","volume":"30","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152163","article-title":"LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p\/PD-L1 axis in prostate cancer","volume":"227","author":"Zhang","year":"2022","journal-title":"Immunobiology"},{"key":"10.1016\/j.critrevonc.2026.105563_bib223","article-title":"shRNA-mediated gene silencing of HDAC11 empowers CAR-T cells against prostate cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105563_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103769","article-title":"Lysine demethylase 5D promotes CHEK1 inhibitor sensitivity through p38-mediated cyclooxygenase-2 expression in castration-resistant prostate cancer cells","volume":"392","author":"zheng","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.critrevonc.2026.105563_bib225","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s42256-022-00527-y","article-title":"Accelerated rational PROTAC design via deep learning and molecular simulations","volume":"4","author":"Zheng","year":"2022","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.critrevonc.2026.105563_bib226","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-20-2828","article-title":"HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4\/6 Inhibitor Resistance in Cancer","volume":"81","author":"Zhou","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105563_bib227","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/jcb.24109","article-title":"TSA-induced JMJD2B downregulation is associated with cyclin B1-dependent survivin degradation and apoptosis in LNCap cells","volume":"113","author":"Zhu","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105563_bib228","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211052977","article-title":"Exosomal miR-1275 secreted by prostate cancer cells modulates osteoblast proliferation and activity by targeting the SIRT2\/RUNX2 cascade","volume":"30","author":"Zou","year":"2021","journal-title":"Cell. Transplant."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:06:26Z","timestamp":1793088386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":228,"alternative-id":["S1040842826004506"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105563","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone erasers in prostate cancer: Clearing the path for progression & therapy resistance","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105563"}}